JP2023549017A5 - - Google Patents
Info
- Publication number
- JP2023549017A5 JP2023549017A5 JP2023518836A JP2023518836A JP2023549017A5 JP 2023549017 A5 JP2023549017 A5 JP 2023549017A5 JP 2023518836 A JP2023518836 A JP 2023518836A JP 2023518836 A JP2023518836 A JP 2023518836A JP 2023549017 A5 JP2023549017 A5 JP 2023549017A5
- Authority
- JP
- Japan
- Prior art keywords
- coronavirus
- protein
- antigens
- vaccine composition
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063112495P | 2020-11-11 | 2020-11-11 | |
| US63/112,495 | 2020-11-11 | ||
| PCT/US2021/058856 WO2022103891A1 (en) | 2020-11-11 | 2021-11-10 | Multivalent carriers and related vaccine compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549017A JP2023549017A (ja) | 2023-11-22 |
| JP2023549017A5 true JP2023549017A5 (cg-RX-API-DMAC10.html) | 2024-11-14 |
Family
ID=81602587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518836A Pending JP2023549017A (ja) | 2020-11-11 | 2021-11-10 | 多価担体および関連するワクチン組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12440553B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4243867A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023549017A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230107304A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117098553A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021378792A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3193843A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL302176A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022103891A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4182687A4 (en) * | 2020-07-20 | 2024-09-11 | Bio-Rad Laboratories, Inc. | IMMUNOASSAY FOR SARS-COV-2 NEUTRALISING ANTIBODIES AND MATERIALS THEREFOR |
| WO2023102476A1 (en) | 2021-12-02 | 2023-06-08 | California Institute Of Technology | Antibodies for coronaviruses and uses thereof |
| WO2024006532A2 (en) * | 2022-06-30 | 2024-01-04 | La Jolla Institute For Immunology | Kari nanoparticle |
| CN117582492A (zh) * | 2022-08-12 | 2024-02-23 | 上海市公共卫生临床中心 | 重组多价疫苗 |
| JP2025529906A (ja) * | 2022-08-22 | 2025-09-09 | ザ ヘンリー エム ジャクソン ファンデイション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド | コロナウイルスに対するワクチン |
| CN115894716B (zh) * | 2022-11-23 | 2024-02-09 | 华中农业大学 | 一种重组融合蛋白纳米颗粒及其制备方法 |
| CN117362447B (zh) * | 2023-08-25 | 2024-04-09 | 广东省农业科学院农业生物基因研究中心 | 一种基于蛋白质偶联聚合体的生物发光酶联免疫分析方法 |
| WO2025255622A1 (en) * | 2024-06-13 | 2025-12-18 | University Of Technology Sydney | Method of vaccine prototyping |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7285289B2 (en) * | 2002-04-12 | 2007-10-23 | Nagy Jon O | Nanoparticle vaccines |
| KR20070052273A (ko) * | 2004-06-30 | 2007-05-21 | 아이디 바이오메디컬 코포레이션 오브 퀘벡 | 코로나바이러스 감염의 치료를 위한 백신 조성물 |
| CA2608515A1 (en) * | 2005-06-01 | 2007-05-10 | Dow Global Technolgies Inc. | Production of multivalent virus like particles |
| RU2628690C2 (ru) * | 2015-11-06 | 2017-08-21 | Общество С Ограниченной Ответственностью 'Фарминтерпрайсез' | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний |
| US20190105282A1 (en) * | 2016-03-23 | 2019-04-11 | Che-Ming Jack Hu | Thin-shell polymeric nanoparticles and uses thereof |
| US12194089B2 (en) * | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
-
2021
- 2021-11-10 CN CN202180075832.8A patent/CN117098553A/zh active Pending
- 2021-11-10 US US17/523,813 patent/US12440553B2/en active Active
- 2021-11-10 JP JP2023518836A patent/JP2023549017A/ja active Pending
- 2021-11-10 AU AU2021378792A patent/AU2021378792A1/en active Pending
- 2021-11-10 CA CA3193843A patent/CA3193843A1/en active Pending
- 2021-11-10 EP EP21892767.1A patent/EP4243867A4/en active Pending
- 2021-11-10 WO PCT/US2021/058856 patent/WO2022103891A1/en not_active Ceased
- 2021-11-10 IL IL302176A patent/IL302176A/en unknown
- 2021-11-10 KR KR1020237019545A patent/KR20230107304A/ko active Pending
-
2025
- 2025-08-12 US US19/298,144 patent/US20260077034A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260137769A1 (en) | Nucleic acid molecules and uses thereof | |
| US11786590B2 (en) | Rotavirus vaccines | |
| US20240002449A1 (en) | Respiratory syncytial virus (rsv) vaccine | |
| Quach et al. | Size-dependent neutralizing activity of gold nanoparticle-based subunit vaccine against dengue virus | |
| JP2001500111A (ja) | ブタの生殖病および呼吸病に対するポリヌクレオチドワクチン処方 | |
| JP2014522842A5 (cg-RX-API-DMAC10.html) | ||
| JP2000515521A (ja) | イヌの症状、特に呼吸器および消化器症状に対するポリヌクレオチドワクチン製剤 | |
| JP2023532290A5 (cg-RX-API-DMAC10.html) | ||
| Kabiri et al. | Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles | |
| US20230136960A1 (en) | Novel MRNA-Based COVID-19 Multi-Valent Vaccine and Methods of Scaled Production of the Same | |
| CA3193843A1 (en) | Multivalent carriers and related vaccine compositions | |
| US20210187096A1 (en) | Universal vaccine for viral diseases | |
| CN116234587A (zh) | 用于诱导免疫应答的免疫原性构建体、组合物和方法 | |
| US9943592B2 (en) | Vaccine adjuvants from self-assembling peptides | |
| KR20130044204A (ko) | 점막 백신 | |
| ES2203436T3 (es) | Composicion de vacuna a base de particulas. | |
| CN116782927A (zh) | 用于提高对抗冠状病毒的免疫力的方法及组合物 | |
| CN118765203A (zh) | 一种新型阳离子佐剂组合物 | |
| US20100166808A1 (en) | Method of Facilitating Intracellular Uptake or Transcellular Transport of Cargo Using Nanocarriers Containing Optimal Surface Densities of Integrin-Specific Ligands | |
| Misra et al. | Nano-adjuvants | |
| TWI771546B (zh) | 針對亨德拉(hendra)及尼帕(nipah)病毒感染之疫苗 | |
| JP2024518548A5 (cg-RX-API-DMAC10.html) | ||
| KR102731640B1 (ko) | 리포펩타이드와 폴리(i:c) 아쥬반트를 포함하는 재조합 코로나-19 백신 조성물 | |
| JPWO2022230485A5 (cg-RX-API-DMAC10.html) | ||
| RU2023114392A (ru) | Днк-кодированные наночастицы и способ их применения в качестве вакцины от коронавирусного заболевания 2019 (covid-19) |